drugset / Trial / NCT06156410
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
Phase 1
Recruiting
30 enrolled
Children's Hospital of Philadelphia
Alex's Lemonade Stand Foundation · collabChildren's Hospital Colorado · collabExelixis · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this study is to better understand how safe and effective the drug cabozantinib in combination with high-dose ifosfamide is in the treatment of children and adults with relapsed/refractory sarcomas.
Timeline
- Start
- 2023-10-24
- Primary completion
- 2027-11
- Completion
- 2028-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cabozantinib | Small molecule | — | — |
| Background | Ifosfamide | Small molecule | — | — |